Ladophar Pharmaceutical Research & Application Co., Ltd announced that it will receive VND 40,000,000,000 in its equity round of funding on April 12, 2022. The transaction includes participation from existing investor Lamdong Pharmaceutical Joint Stock Company. Post-closing of the transaction, the investor will retain its 100% stake in the company.